Mirae Asset Global Investments Co., Ltd. Amgen Inc Transaction History

Mirae Asset Global Investments Co., Ltd.

$20 Billion
Q2 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 347,035 shares of AMGN stock, worth $111 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

347,035

Previous 734,632 52.76%

Holding current value

$111 Million

Previous $209 Million 48.09%

% of portfolio

0.54%

Previous 0.38%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$262.75 - $319.31 $102 Million - $124 Million	-387,597 Reduced 52.76%	347,035 $108 Million
Q1 2024 May 01, 2024	BUY	$268.87 - $324.56 $15.2 Million - $18.3 Million	56,376 Added 8.31%	734,632 $209 Million
Q4 2023 Jan 24, 2024	SELL	$255.7 - $288.46 $1.44 Million - $1.62 Million	-5,617 Reduced 0.82%	678,256 $195 Million
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $22.2 Million - $27.6 Million	101,754 Added 17.48%	683,873 $184 Million
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $580,457 - $686,379	2,709 Added 0.47%	582,119 $129 Million
Q1 2023 May 04, 2023	BUY	$225.79 - $275.2 $3.33 Million - $4.06 Million	14,770 Added 2.62%	579,410 $140 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $1.15 Million - $1.47 Million	-5,042 Reduced 0.89%	564,640 $148 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $290,900 - $328,082	-1,296 Reduced 0.23%	569,682 $128 Million
Q2 2022 Jul 26, 2022	BUY	$230.71 - $256.74 $17.6 Million - $19.6 Million	76,240 Added 15.41%	570,978 $139 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $24.7 Million - $27.3 Million	112,495 Added 29.43%	494,738 $120 Million
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $12.3 Million - $14.1 Million	61,834 Added 19.3%	382,243 $86 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $14.3 Million - $16.8 Million	67,551 Added 26.71%	320,409 $68.1 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $11.9 Million - $13.2 Million	50,906 Added 25.21%	252,858 $61.6 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $11.2 Million - $13.1 Million	-50,531 Reduced 20.01%	201,952 $50.2 Million
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $8.15 Million - $9.71 Million	37,678 Added 17.54%	252,483 $58.1 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $5.93 Million - $6.6 Million	25,286 Added 13.34%	214,805 $54.6 Million
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $2.16 Million - $2.65 Million	10,903 Added 6.1%	189,519 $44.7 Million
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $3.96 Million - $5.25 Million	21,703 Added 13.83%	178,616 $36.2 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $3.32 Million - $4.26 Million	17,534 Added 12.58%	156,913 $37.8 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $1.82 Million - $2.18 Million	10,434 Added 8.09%	139,379 $27 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $17,836 - $20,908	107 Added 0.08%	128,945 $23.8 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $2.23 Million - $2.51 Million	12,315 Added 10.57%	128,838 $24.4 Million
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $2.14 Million - $2.5 Million	11,996 Added 11.48%	116,523 $22.7 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $3.45 Million - $3.89 Million	18,611 Added 21.66%	104,527 $21.7 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $1.05 Million - $1.18 Million	6,340 Added 7.97%	85,916 $15.8 Million
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $287,014 - $335,412	-1,694 Reduced 2.08%	79,576 $13.6 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $1.55 Million - $1.73 Million	9,198 Added 12.76%	81,270 $14.1 Million
Q3 2017 Nov 08, 2017	SELL	$167.29 - $191.0 $476,776 - $544,350	-2,850 Reduced 3.8%	72,072 $13.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	74,922	74,922 $12.9 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Amgen Inc Transaction History